Allopurinol blocks xanthine oxidase, the enzyme that produces uric acid. Lowering urate dissolves the crystals that have accumulated in joints and prevents new ones forming, which over time stops gout attacks and prevents joint damage. It does nothing for an attack in progress. Worse, starting it triggers attacks - and the commonest mistake people make is stopping it at exactly the moment they should continue.
Follow the instructions on your label. This guide contains no doses.
Why it causes attacks at first
Lowering blood urate mobilises crystals that have been sitting quietly in the joints. As they dissolve and shift, they provoke inflammation.
Attacks in the first weeks and months of treatment are therefore common and expected - and they are the reason people conclude the treatment is not working and abandon it.
Two things address this:
Start low and increase slowly, which reduces the mobilisation.
Take prophylaxis alongside - low-dose colchicine, or an anti-inflammatory, for the first several months. That is a deliberate part of the plan, not an oversight. See colchicine.
Do not stop it during an attack
This is the single most important practical point.
Any change in urate level - up or down - can provoke an attack. Stopping allopurinol mid-attack causes urate to rise, which prolongs the attack rather than helping it.
Continue allopurinol through an attack and treat the attack separately with colchicine, an anti-inflammatory or a short course of steroids.
See prednisolone and naproxen and ibuprofen.
Equally, allopurinol is usually started after an attack has settled rather than during one - though evidence suggests starting during an attack with cover is acceptable.
Treat to target
Allopurinol is not a fixed-dose medicine. The dose is increased until blood urate reaches a target - commonly below a defined level, and lower still where there are visible tophi.
Many people are left on a low starting dose indefinitely with urate still above target, and continue having attacks as a result.
Ask what your urate level is and what the target is. If you still get attacks after a year of treatment, that is usually a dose problem rather than a drug failure.
See monitoring long-term medicines and gout medicines.
The azathioprine interaction
This one can kill. Azathioprine and mercaptopurine are broken down by xanthine oxidase - the enzyme allopurinol blocks.
Combining them without a large dose reduction causes severe bone marrow suppression, and deaths have resulted.
The combination is sometimes used deliberately at greatly reduced azathioprine doses under specialist supervision. It must never happen by accident.
If you take azathioprine or mercaptopurine, make certain anyone prescribing allopurinol knows.
The rash means stop
Rash is a recognised effect, and most are mild - but allopurinol is associated with severe hypersensitivity reactions including Stevens-Johnson syndrome, toxic epidermal necrolysis and DRESS, which can be fatal.
Stop the medicine and seek urgent medical advice for any rash developing on allopurinol, particularly with fever, blistering, peeling skin, facial swelling, or sores in the mouth or eyes.
The risk is higher in the first months, in kidney impairment, and in people carrying the HLA-B*5801 variant - considerably more common in people of Han Chinese, Thai and Korean ancestry, where testing before starting is recommended.
Kidney function
Allopurinol is cleared by the kidneys, and the starting dose is reduced in impairment - though the dose is still increased to target, more slowly.
Historically people with kidney disease were kept on very low doses indefinitely and never reached target. Current practice is to titrate carefully rather than cap arbitrarily.
Other side effects and interactions
Nausea, diarrhoea and headache are common early and reduced by taking it after food.
Liver enzymes can rise - report jaundice or persistent nausea.
Allopurinol increases the effect of warfarin, and combined with an ACE inhibitor or a thiazide diuretic the hypersensitivity risk appears higher - see warfarin.
Diuretics raise urate and are a common cause of gout, frequently overlooked - see furosemide. Low-dose aspirin also raises it slightly.
Febuxostat
Febuxostat lowers urate by the same enzyme and is an alternative where allopurinol is not tolerated or does not reach target.
A trial raised a question about cardiovascular mortality compared with allopurinol, so it is used with caution in people with significant cardiovascular disease.
Is it for life?
Usually. Urate rises again within weeks of stopping and attacks return.
Alongside it, reducing alcohol - beer particularly - and sugary drinks helps, and weight loss lowers urate. But diet alone rarely achieves target in someone who needs treatment.
See also Hydroxychloroquine: Long-Term Use and Eye Checks, and the Conditions section for more on what medicines are prescribed for.